About US
Contact us
-
FDA approves Vivitrol for treatment of opioid-dependent patientsFDA approves injectable drug to treat opioid-dependent patients The U.S. Food and Drug Administration today approved Vivitrol to treat and prevent relapse after patients with opioid dependence h2010/10/14
-
Actavis receives FDA marketing approval for generic CozaarActavis receives FDA marketing approval for generic Cozaar Actavis Group, the international generic pharmaceuticals company, today announced that it has received approval from the US Food & Dr2010/10/14
-
Evonik expands capacities for extruded PLEXIGLAS® sheets with an abrasion-resistant coating in WeiterstadtEvonik expands capacities for extruded PLEXIGLAS® sheets with an abrasion-resistant coating in Weiterstadt Darmstadt, Germany, October 11, 2010 New extrusion line with annual capacity of 10,002010/10/13
-
BASF receives CPhI Silver Innovation AwardsBASF receives CPhI Silver Innovation Awards · Soluplus®: The Solid Solution wins award at CPhI in Paris · Soluplus helps pharmaceutical companies formulate hardly soluble drugs As a matrix po2010/10/13
-
Sales of Merck's telcagepant and CoLucid's lasmiditan in world's major markets to reach $1.3 billion in 2019Sales of Merck's telcagepant and CoLucid's lasmiditan in world's major markets to reach $1.3 billion in 2019 Decision Resources, one of the world's leading research and advisory firms for pharmace2010/10/12
-
Abbott to withdraw sibutramine from Canadian marketAbbott to withdraw sibutramine from Canadian market Abbott will voluntarily withdraw sibutramine from the Canadian market after discussion with Health Canada. Sibutramine is marketed by Abbott in2010/10/12
-
BASF to establish STYROLUTION as a leading company in styrenics· Existing BASF styrenics activities to be transferred to separate companies · STYROLUTION to focus on customers in styrenics business Ludwigshafen, Germany – October 7, 2010 – BASF is continui2010/10/11
-
Biologists determine three-dimensional structure of molecule involved in HIV, cancerIn a technical tour de force, structural biologists funded by the National Institutes of Health have determined the three-dimensional structure of a molecule involved in HIV infection and in many f2010/10/11
-
BASF focuses on Ecovio® and Ecoflex®· Expanded Ecoflex plant in Ludwigshafen to go on stream at the end of 2010 · BASF expects significant market growth for biodegradable plastics through to 2020 Ludwigshafen , Germany – Octobe2010/10/9
-
Onyx Pharmaceuticals announces delay in NDA filing for carfilzomibOnyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will delay its New Drug Application (NDA) filing for carfilzomib based on a recent meeting with the Chemistry, Manufacturing and Contr2010/10/9